NIVO-TIL: Combination Anti-Pd-1 Therapy and Adoptive T-cell Transfer in Untreated Metastatic Melanoma: an Exploratory Open-Label Phase I Trial
ACTA ONCOLOGICA（2024）
Key words
Melanoma,immunotherapy,anti-PD-1,TIL,adoptive cell transfer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined